Bibliometric analysis of olaparib and pancreatic cancer from 2009 to 2022: A global perspective

Figure 3 Analysis of countries/regions. A: Countries’ production throughout the year; B: Deformed geographical distribution map of global productivity related to olaparib in pancreatic cancer. The area and color represent the number of publications; C: Geographical distribution map and collaboration map of publications related to olaparib in pancreatic cancer. Node size and color represent the number of publications; D: Global collaboration and time evolution of countries/regions in this field. The colors of the nodes represent the average number of publications annually.